Press Releases

Date

Title

View

10 Feb 20

4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features)

View View

21 Jan 20

4basebio AG: 4basebio AG decides to buy back 2 million treasury shares (news with additional features)

View View

21 Jan 20

4basebio AG: Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB (news with additional features)

View View

02 Jan 20

Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction (news with additional features)

View View

19 Dec 19

Expedeon AG: Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG (news with additional features)

View View

21 Nov 19

Expedeon AG: Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main (news with additional features)

View View

20 Nov 19

Expedeon AG: Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website (news with additional features)

View View

11 Nov 19

Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

View View

07 Nov 19

Expedeon AG: Expedeon AG reports third quarter 2019 financial results with strongest ever revenues and EBITDA (news with additional features)

View View

29 Oct 19

Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 (news with additional features)

View View

04 Oct 19

Expedeon AG: Expedeon AG announces conversion to registered shares (news with additional features)

View View

14 Aug 19

Expedeon AG: Expedeon AG reports strong financial results for the first six months of 2019, reaffirming positive trend (news with additional features)

View View